Publication | Closed Access

Metformin relieves H/R-induced cardiomyocyte injury through miR-19a/ACSL axis - possible therapeutic target for myocardial I/R injury

InflammationCardiac MuscleCardiomyopathyMyocardial I/r InjuryCardiovascular DiseaseMir-19a/acsl AxisCell BiologyH/r-induced Cardiomyocyte InjuryMedicineCardiac ReprogrammingCardiologyMyocardial Infarction